Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis

A Leonardi1, A Di Stefano, L Motterle

  • 1Ophthalmology Unit, Department of Neuroscience, University of Padua, Padua, Italy. andrea.leonardi@unipd.it

Abstract

Insights

The TGF-β/Smad pathway is overactive in Vernal Keratoconjunctivitis (VKC), a chronic allergic eye inflammation. This pathway is influenced by common allergy mediators, suggesting new therapeutic targets for VKC treatment.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Vernal keratoconjunctivitis (VKC) is a chronic allergic eye inflammation causing corneal issues and giant papillae.
  • Sma- and Mad-related proteins (Smad) are key regulators of extracellular matrix gene expression in healing and inflammation.

Purpose of the Study:

  • To investigate the link between allergic inflammation and the TGF-β/Smad signaling pathway in VKC patients.
  • To examine the expression of this pathway in conjunctival fibroblasts exposed to VKC-associated mediators.

Main Methods:

  • Immunohistochemistry was used to evaluate Smad proteins, TGF-β1, TGF-β2, and pro-collagen I (PIP) in conjunctival tissues from VKC patients and controls.
  • Conjunctival fibroblast cultures were exposed to histamine, IL-4, IL-13, TGF-β1, IFN-γ, and TNF-α to assess Smad expression, PIP, and MAPK pathway activation via immunostaining and RT-PCR.

Main Results:

  • Smad-2, -3, phospho-Smads, TGF-β1, -β2, and PIP were significantly elevated in VKC conjunctival stroma.
  • Histamine, IL-4, IL-13, and TGF-β1 stimulated Smad-3 and PIP expression in fibroblasts, while IFN-γ reduced PIP.
  • Histamine, IL-4, and TNF-α modulated Smad-3 and Smad-7 expression and activated JNK and ERK1/2 pathways.

Conclusions:

  • The TGF-β/Smad signaling pathway is upregulated in VKC and responsive to inflammatory mediators.
  • These findings suggest a role for the TGF-β/Smad pathway in collagen production, giant papillae formation, and tissue remodeling in VKC.
  • The pathway presents potential therapeutic targets for managing VKC.